DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kalshetty A, Ramaswamy A, Ostwal V, Basu S.
Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: Efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting.
Nucl Med Commun 2018;
39: 1143-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.